Merck Frosst
Patients & Caregivers Contact Us Français
Patients & CaregiversContact UsFrançais
Home

JANUVIATM

Press Releases

Jan 03, 2008 Health Canada approves once-daily JanuviaTM, the first treatment in a new class of medicines for type 2 diabetes 
June 26, 2007

Data Released at ADA Showed that Sitagliptin and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes

June 13, 2006 New Data On Sitagliptin, An Investigational Once-Daily Medicine For Type 2 Diabetes

Monograph / Prescribing Information / Product Information

Click here

Studies

Disease Fact Sheets

Product Fact Sheets

Jan 03, 2008 Diabetes in Canada - Fact Sheet
Jan 03, 2008 DPP-4 Inhibitors - Fact Sheet
Jan 03, 2008 Fact Sheet - JANUVIATM

Photos

B-Roll

What's New
Contact
Media contacts.
Printer friendly

This site is for residents of Canada. / This site was updated on May 2, 2008.